These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

506 related items for PubMed ID: 26464713

  • 1. Prognostic significance of microRNA-203 in cholangiocarcinoma.
    Li J, Gao B, Huang Z, Duan T, Li D, Zhang S, Zhao Y, Liu L, Wang Q, Chen Z, Cheng K.
    Int J Clin Exp Pathol; 2015; 8(8):9512-6. PubMed ID: 26464713
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA-144 suppresses cholangiocarcinoma cell proliferation and invasion through targeting platelet activating factor acetylhydrolase isoform 1b.
    Yang R, Chen Y, Tang C, Li H, Wang B, Yan Q, Hu J, Zou S.
    BMC Cancer; 2014 Dec 05; 14():917. PubMed ID: 25479763
    [Abstract] [Full Text] [Related]

  • 3. Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma.
    Wu X, Xia M, Chen D, Wu F, Lv Z, Zhan Q, Jiao Y, Wang W, Chen G, An F.
    Tumour Biol; 2016 Nov 05; 37(11):15019-15029. PubMed ID: 27658773
    [Abstract] [Full Text] [Related]

  • 4. The Prognostic Role of SOCS3 and A20 in Human Cholangiocarcinoma.
    Wang Y, Wan M, Zhou Q, Wang H, Wang Z, Zhong X, Zhang L, Tai S, Cui Y.
    PLoS One; 2015 Nov 05; 10(10):e0141165. PubMed ID: 26485275
    [Abstract] [Full Text] [Related]

  • 5. SOX4 is associated with poor prognosis in cholangiocarcinoma.
    Wang W, Zhang J, Zhan X, Lin T, Yang M, Hu J, Han B, Hu S.
    Biochem Biophys Res Commun; 2014 Sep 26; 452(3):614-21. PubMed ID: 25181339
    [Abstract] [Full Text] [Related]

  • 6. Ars2 is overexpressed in human cholangiocarcinomas and its depletion increases PTEN and PDCD4 by decreasing microRNA-21.
    He Q, Cai L, Shuai L, Li D, Wang C, Liu Y, Li X, Li Z, Wang S.
    Mol Carcinog; 2013 Apr 26; 52(4):286-96. PubMed ID: 22213145
    [Abstract] [Full Text] [Related]

  • 7. Circulating miR-192 in liver fluke-associated cholangiocarcinoma patients: a prospective prognostic indicator.
    Silakit R, Loilome W, Yongvanit P, Chusorn P, Techasen A, Boonmars T, Khuntikeo N, Chamadol N, Pairojkul C, Namwat N.
    J Hepatobiliary Pancreat Sci; 2014 Dec 26; 21(12):864-72. PubMed ID: 25131257
    [Abstract] [Full Text] [Related]

  • 8. Sirtuin7 has an oncogenic potential via promoting the growth of cholangiocarcinoma cells.
    Li W, Sun Z, Chen C, Wang L, Geng Z, Tao J.
    Biomed Pharmacother; 2018 Apr 26; 100():257-266. PubMed ID: 29438839
    [Abstract] [Full Text] [Related]

  • 9. A novel three‑miRNA signature predicts survival in cholangiocarcinoma based on RNA‑Seq data.
    Cao J, Sun L, Li J, Zhou C, Cheng L, Chen K, Yan B, Qian W, Ma Q, Duan W.
    Oncol Rep; 2018 Sep 26; 40(3):1422-1434. PubMed ID: 29956786
    [Abstract] [Full Text] [Related]

  • 10. Methyl-CpG binding protein MBD2 is implicated in methylation-mediated suppression of miR-373 in hilar cholangiocarcinoma.
    Chen Y, Gao W, Luo J, Tian R, Sun H, Zou S.
    Oncol Rep; 2011 Feb 26; 25(2):443-51. PubMed ID: 21165562
    [Abstract] [Full Text] [Related]

  • 11. Serum miR-26a as a diagnostic and prognostic biomarker in cholangiocarcinoma.
    Wang LJ, Zhang KL, Zhang N, Ma XW, Yan SW, Cao DH, Shi SJ.
    Oncotarget; 2015 Jul 30; 6(21):18631-40. PubMed ID: 26087181
    [Abstract] [Full Text] [Related]

  • 12. Hepatocyte nuclear factor 6 inhibits the growth and metastasis of cholangiocarcinoma cells by regulating miR-122.
    Zhu H, Mi Y, Jiang X, Zhou X, Li R, Wei Z, Jiang H, Lu J, Sun X.
    J Cancer Res Clin Oncol; 2016 May 30; 142(5):969-80. PubMed ID: 26825606
    [Abstract] [Full Text] [Related]

  • 13. miR-378 serves as a prognostic biomarker in cholangiocarcinoma and promotes tumor proliferation, migration, and invasion.
    Zhou Z, Ma J.
    Cancer Biomark; 2019 May 30; 24(2):173-181. PubMed ID: 30594918
    [Abstract] [Full Text] [Related]

  • 14. Circulating microRNA-21 as a prognostic, biological marker in cholangiocarcinoma.
    Liu CH, Huang Q, Jin ZY, Xie F, Zhu CL, Liu Z, Wang C.
    J Cancer Res Ther; 2018 Jan 30; 14(1):220-225. PubMed ID: 29516989
    [Abstract] [Full Text] [Related]

  • 15. Dysregulated microRNA expression profiles in cholangiocarcinoma cell-derived exosomes.
    Kitdumrongthum S, Metheetrairut C, Charoensawan V, Ounjai P, Janpipatkul K, Panvongsa W, Weerachayaphorn J, Piyachaturawat P, Chairoungdua A.
    Life Sci; 2018 Oct 01; 210():65-75. PubMed ID: 30165035
    [Abstract] [Full Text] [Related]

  • 16. Circular RNA CDR1as Exerts Oncogenic Properties Partially through Regulating MicroRNA 641 in Cholangiocarcinoma.
    Li D, Tang Z, Gao Z, Shen P, Liu Z, Dang X.
    Mol Cell Biol; 2020 Jul 14; 40(15):. PubMed ID: 32423991
    [Abstract] [Full Text] [Related]

  • 17. miR-383 promotes cholangiocarcinoma cell proliferation, migration, and invasion through targeting IRF1.
    Wan P, Chi X, Du Q, Luo J, Cui X, Dong K, Bing Y, Heres C, Geller DA.
    J Cell Biochem; 2018 Dec 14; 119(12):9720-9729. PubMed ID: 30145803
    [Abstract] [Full Text] [Related]

  • 18. Overexpression of miR-27a predicts poor prognosis and promotes the progression in cholangiocarcinoma.
    Liu Y, Liu X, Zhou Y, Liu T, Li J.
    Clin Exp Med; 2021 Feb 14; 21(1):121-128. PubMed ID: 32816152
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA-191 acts as a tumor promoter by modulating the TET1-p53 pathway in intrahepatic cholangiocarcinoma.
    Li H, Zhou ZQ, Yang ZR, Tong DN, Guan J, Shi BJ, Nie J, Ding XT, Li B, Zhou GW, Zhang ZY.
    Hepatology; 2017 Jul 14; 66(1):136-151. PubMed ID: 28194813
    [Abstract] [Full Text] [Related]

  • 20. MORC2 promotes cell growth and metastasis in human cholangiocarcinoma and is negatively regulated by miR-186-5p.
    Liao G, Liu X, Wu D, Duan F, Xie X, Wen S, Li Y, Li S.
    Aging (Albany NY); 2019 Jun 09; 11(11):3639-3649. PubMed ID: 31180332
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.